Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity
2024

Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity

publication Evidence: moderate

Author Information

Author(s): Croes Cresci-Anne C. C., Chrysanthou Marialena, Hoppenbrouwers Tamara, Wichers Harry, Keijer Jaap, Savelkoul Huub F. J., Teodorowicz Malgorzata

Primary Institution: Wageningen University and Research Centre

Hypothesis

Different glycation methods of human serum albumin (HSA) uniquely alter its structure, impacting binding to AGE receptors and macrophage activation.

Conclusion

The type of HSA glycation impacts immune functional readouts with potential relevance for diabetes.

Supporting Evidence

  • Glycation of HSA with MGO showed the highest binding to AGE receptors.
  • HSA–CML led to a significantly higher inflammatory response in macrophages.
  • Different glycation methods resulted in unique AGE profiles and distinct impacts on protein structure.
  • HSA–MGO induced the highest expression of pro-inflammatory markers in THP-1 macrophages.
  • Each glycation method altered the binding affinity of HSA to AGE receptors.

Takeaway

When sugar attaches to a protein in the blood, it can change how that protein works and how the body reacts to it, especially in diabetes.

Methodology

HSA was glycated using D-glucose, methylglyoxal (MGO), or glyoxylic acid (CML), and various biochemical methods were used to analyze the effects on protein structure and immune response.

Limitations

The study's in vitro conditions may not fully replicate the complex in vivo environment of diabetes.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/biom14121492

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication